• 대한화장품학회지
• /
• 제41권2호
• /
• pp.143-150
• /
• 2015

본 연구는 3,7-diarylpyrazolo [1,5-${\alpha}$]pyrimidines의 효과적인 one-pot regioselective 합성을 보여준다. 더욱이, 그 유도체는 뛰어난 CB1R 저해 활성을 나타냈다. 3,7-position에 diaryl group이 치환된 pyrazolo [1,5-${\alpha}$]pyrimidine은 CB1R 후보로서 가능성 있는 pharmacophore이다.

• Bulletin of the Korean Chemical Society
• /
• 제35권2호
• /
• pp.617-621
• /
• 2014

An efficient and selective method for the synthesis of ethyl 2-amino/aryloxy-3-aryl-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylate derivatives has been developed. The main process involved the reaction of diethyl 1-phenyl-3-((triphenylphosphoranylidene)amino)-1H-pyrrole-2,4-dicarboxylate and aromatic isocyanates, followed by addition of amines/phenols in the presence of catalytic amount of sodium ethoxide or solid potassium carbonate.

• Archives of Pharmacal Research
• /
• 제20권4호
• /
• pp.330-337
• /
• 1997

Thiocarboxamidocinnamonitrile derivatives 2 under bar a-f reacted with 3-aminopyrazole derivative 3 under bar a-c to give the pyrazole[3, 2-b]pyrimidine derivatives 6 under bar a-p. Compounds 6 under bar a-p were used as starting material for syntheses of several heterocylic coompounds. Dehydrogenation of 6 under bar gave pyrazole[3, 2-b]pyrimidines 10 under bar a-d while its reaction with diethyl oxalate gave 11 under bar. Reactions of 6 under bar with formic acid gave pyrazolopyrimidines 17 under bar a-j, and pyrazolopyrimidopyrimidines 18 under bar a-j.

• Archives of Pharmacal Research
• /
• 제15권1호
• /
• pp.69-72
• /
• 1992

Pyrimidine bases and their mucleosides were oxidatively iodinated at C-5 position by the reaction of iodine in DMF (dimethylformamide) with MCPBA (m-chloroperbenzoic acid) under mild conditions. For uracil derivatives such as uracil 1a. 1, 3-dimethyluracil 1b, uridine 1c, and 2'-deoxyuridine 1d, the corresponding 5-iodo derivatives were obtained in high yields (71-95%). The iodination of cytidine 3a and 2'-deoxycytidine 3b was achieved in moderate yields (41-56%).

• Parasites, Hosts and Diseases
• /
• 제28권2호
• /
• pp.79-84
• /
• 1990

Pyrimidine salvage과정 및 de novo 합성과정에 작용하는 억제제들이 Toxeplasma gondii의 특이한 uracil 도입 과정에 미치는 영향을 방사능을 표지한 uracil과 thymidine을 사용하여 검토하였다. Dihydrofolate reductase (DHFR)에 작용하는 억제제인 methotreBate, pyrimethamine 그리고 thymidylate synthase(75)의 경쟁적 억제제인 fluoro-uridine, fluoro-dUMP, fluoro-uracil을 각각 처리한 경우, 그 농도에 비례적으로 uracil 표지가 감소 하였다. OMP decarboxylase에 작용하는 억제제인 azauridine에 대해서는 100$\mu$M 농도 이상에서도 uracil 표지량에 변화가 거의 없었다. 본 결과로부터 Toxoplasma가 uracil을 DNA로 도입할 때 dihydrofolate reductase와 thymidylate synthase가 관여하는 TMP biosynthesis 과정이 중요함을 알 수 있었고, uracil salvage 과정이 있는 다른 기생성 원충의 경우와 비교했을 때 Toxoplasmn에 있어서도 효율적인 다기능의 DHFR-75 system의 존재를 예상할 수 있었다. Thymidine 도입의 양상은 모든 경우에 있어 HL-60세포만의 경우와 Toxoplasma가 함께 배양된 HL-60세포에서 차이가 없었다. 이로부터 thymidine은 Toxoplasmn 성장을 반영하지 않음을 알 수 있었다. Toxoplasma의 특이한 uracil 표지와 Toxoplasma에 배타적인 thymidine 표지는 기생원충과 숙주세포의 성장, DNA합성 정도 및 이들 과정에 미치는 제제들의 영향을 쉽고 간단하게 연구할 수 있는 방법이 된다.

• Archives of Pharmacal Research
• /
• 제15권4호
• /
• pp.317-321
• /
• 1992

Furoyldroximoyl chloride 3d reacted with 2-aminopyridine, 2-aminopyrimidine. O-aminophenol, O-phenylenediamine and aminothiophenol to afford imidazo [1, 2-a]pyridine 6. imidazo[1, 2-a]pyrimidine 8, benzoxadiazine 10, nitrosobenzopyrizine 13a and nitrosobenzothiazine 13b, respectively. Isoxazoline 18 and pyrrolidino[3, 4-d]isoxazolin-4, 6-dione derivatives 19a and 19b obtained by the reaction of 3 with acrylonitrile and N-arylmaleimide. Hydroximoyl chloride 3 reacted with thiophenol and sodium benzene-sulfinate to yield furylglyoxaloxime 16a and 16b, respectively. Hydroximoyl chloride 3 reacted also with some active methylene compound to give isoxazole derivatives 20-23, respectively.

• Bulletin of the Korean Chemical Society
• /
• 제24권10호
• /
• pp.1429-1432
• /
• 2003

A novel fused thiouracil containing a heterocyclic ring system, dipyrimidinopyridine (3), has been prepared through the cyclization of compound 2. Compound 2 was formed by the formylation of 6-amino-2-thiouracil 1, pyrazolopyrimidines 8-10 via the heating of 6-arylhydrazono-2-thiouracils 5-7, compound 11, using Vilsmeier reagent with compound 4, pyrazolylpyrimidine 12, indolodiazinopyrimidine 14 and pyridazinopyrimidine 15. Pyridazino-pyrimidine 15 was formed by the condensation of compound 4 with acetylacetone, isatin and benzyl, respectively.

• Bulletin of the Korean Chemical Society
• /
• 제25권7호
• /
• pp.991-996
• /
• 2004

New series of 6-(arylthio)uracils, 6-(4-substituted-1-piperazinyl)uracils, 2,4,5-trioxo-1H,3H-benzothiopyrano[2,3-d]pyrimidine and 5-aryl-2,4-dioxo-1H,3H-pyrimido[5,4-f]benzo[1,4]thiazepines have been prepared and screened for their in vitro activity against herpes simplex-1 virus (HSV-1) and human immunodeficiency virus-1 (HIV-1). The in vitro cytotoxic activity was also evaluated. The results of biological testing revealed that compound 5b showed marginal activity against HSV-1, while compounds 5b and 5f exhibited marginal activity against HIV-1. The rest of the tested compounds were found devoid of antiviral activity against both HSV-1 and HIV-1.

• 대한약리학회지
• /
• 제26권1호
• /
• pp.91-100
• /
• 1990

Benzylacyclouridines (BAU and BBAU)는 uridine phosphorylase (UrdPase)의 선택적이고 강력한 상경억제제이다. 보고된 바에 의하면 (Cancer Res., 44: 1852, 1984) Benzylacyclouridines가 5-fluoro-2'-deoxyuridine (FdUrd)의 인체 암세포에 대한 독성을 증가시켜 준다고 하였지만, L5187Y 세포를 사용한 본 실험에서는 Benzylacyclouridines가 FdUrd를 포함하여 5-fluorouridine (FUra) 모두에 대해 조금도 세포 독성을 증가시키지 못하였을 뿐만아니라, 오히려 세포를 그들 독성으로부터 투여량에 비례하여 보호하였다. 복강내 주사에 의한 생체실험에서도 Benzylacyclouridines는 5-fluorinated pyrimidine에 의한 L5187Y를 지닌 쥐(mouse)의 life-span을 연장시켜 주지 못하였다. 본 실험에서 Benzylacyclouridines가 기대했던 fluorinated pyrimidine 항암제의 효과를 증진시키지 못한 이유는 nucleosides의 anabolism이 UrdPase와 orotate phosphoribosyltransferase이 의한 sequential 작용에 의하던가 또는 Benzylacyclouridines에 의한 nucleosides의 수송억제에 의하던가, 아니면 두가지 다 복합적으로 작용한 결과로 생각된다.

• Bulletin of the Korean Chemical Society
• /
• 제35권12호
• /
• pp.3502-3508
• /
• 2014

The first synthetic route to 5'-norcarbocyclic C-nucleoside [7-oxa-7,9-dideazadenosine (furo[3,2-d]pyrimidine) and 9-deazaadenosine (pyrrolo[3,2-d]pyrimidine)] phosphonic acids from commercially available 1,3-dihydroxy cyclopentane was described. The key C-C bond formation from sugar to base precursor was performed using Knoevenagel-type condensation from a ketone derivative. Synthesized C-nucleoside phosphonic acids were tested for anti-HIV activity as well as anti-leukemic activity. Compound 26 showed significant anti-leukemic activity.